Table S2 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

Ignacio Campillo‐Marcos; Marta Casado-Peláez; Verónica Dávalos; Gerardo Ferrer; Caterina Mata; Elisabetta Mereu; Gaël Roué; David Valcárcel; Antonieta Molero; Lurdes Zamora; Blanca Xicoy; Laura Palomo; Pamela Acha; Ana Manzanares; Magnus Tobiasson; Eva Hellström‐Lindberg; Françesc Solé; Manel Esteller

doi:10.1158/2767-9764.25206422

February 12, 2024Open Access

Table S2 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

View Full Paper

Ask AI

Bookmark

Share

Key Points

Amplicon coverage metrics define targeted genomic performance for custom single-cell DNA sequencing panels in myelodysplastic syndromes, establishing technical baseline data.
Assessment of custom single-cell DNA sequencing panels measures targeted amplicon coverage across multiomics analysis datasets to evaluate high-resolution genomic detection depth.
Detailed amplicon coverage profiles may enable refined monitoring of myelodysplastic syndromes and therapeutic tracking during hypomethylating therapy across single-cell cohorts.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Multiomics analysis demonstrates custom single-cell DNA sequencing amplicon coverage in myelodysplastic syndromes, highlighting targeted genomic profiling metrics.

Abstract

Amplicon coverage for the custom single cell DNA sequencing panel

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Campillo‐Marcos et al. (2024) studied this question.

synapsesocial.com/papers/68e79856b6db643587709029 https://doi.org/10.1158/2767-9764.25206422

View Full Paper

Ask AI

Bookmark

Share

Table S2 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Table S2 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers